Adam M. Koppel
InvestorFounderPartner at Bain Capital Life Sciences · Board director at Areteia Therapeutics · Board director at Cardurion Pharmaceuticals, Inc. · Board director at Solid Biosciences
Boston
Writes $100K – $5M checks · typically $1.5M
FoundedAreteia TherapeuticsCardurion Pharmaceuticals, Inc.Solid Biosciences
About
Adam M. Koppel is a Partner on the Life Sciences team at Bain Capital, which he first joined in 2003 and rejoined in 2016, having earlier been part of the firm's Public Equity team focused on healthcare. Between his stints at Bain Capital, he served as EVP of Corporate Development and Chief Strategy Officer at Biogen, and prior to that was an Associate Principal at McKinsey & Company. He holds an MD and PhD in neuroscience and an MBA from the University of Pennsylvania, and an AB and AM in history and science from Harvard University.
Invests in
Biotech
Board director at Areteia Therapeutics
Intro paths
In turn, Adam can intro founders to Areteia Therapeutics's investors below.
Areteia Therapeutics's investors · 3
Co-founders at Areteia Therapeutics
Board director at Cardurion Pharmaceuticals, Inc.
Intro paths
In turn, Adam can intro founders to Cardurion Pharmaceuticals, Inc.'s investors below.
Cardurion Pharmaceuticals, Inc.'s investors · 5
Co-founders at Cardurion Pharmaceuticals, Inc.
Board director at Solid Biosciences
Intro paths
In turn, Adam can intro founders to Solid Biosciences's investors below.
Solid Biosciences's investors · 3
Co-founders at Solid Biosciences
Experience
- Bain CapitalManaging Directorcurrent2016 — presentBoston, MA
- BiogenEVP, Corporate Development & Strategy2014 — 2016Cambridge, MA
- Bain CapitalManaging Director2003 — 2014
- McKinsey & CompanyAssociate Principal2000 — 2004
Education
- Harvard University1987 — 1991
- University of Pennsylvania School of MedicineMD, PhD1991 — 1999
- The Wharton SchoolMBA, Finance1999 — 2000
Skills & more
+8 more
HealthcareFinancial ModelingStart-upsHedge FundsEquity ResearchPortfolio ManagementCompetitive AnalysisPharmaceutical IndustryFrom Adam's professional profile.
Deals · 4
Areteia TherapeuticsBoard seat
via Bain Capital Life Sciences · filed Feb 2025 · $445M raise
Cardurion Pharmaceuticals, Inc.Board seat
via Bain Capital Life Sciences · filed Jul 2023 · $128.1M raise
Solid BiosciencesBoard seat
via Bain Capital Life Sciences · filed Oct 2020 · $40M raise
AptinyxBoard seat
via Bain Capital Life Sciences · filed Dec 2017 · $70M raise
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at Bain Capital Life Sciences
Network9
Investors connected to Adam in public investor directories — a warm-intro map.
Frequently asked questions
- Where does Adam M. Koppel work?
- Adam M. Koppel is Partner at Bain Capital Life Sciences and Founder at Areteia Therapeutics and Founder at Cardurion Pharmaceuticals, Inc. and Founder at Solid Biosciences.
- What does Adam M. Koppel invest in?
- Adam M. Koppel invests in Biotech.
- What check size does Adam M. Koppel write?
- Adam M. Koppel typically writes checks of $100K – $5M.
- What companies did Adam M. Koppel found?
- Adam M. Koppel founded Areteia Therapeutics, Cardurion Pharmaceuticals, Inc., Solid Biosciences.
Same school
Also attended Harvard University1,465
+ 1,459 more
Also attended University of Pennsylvania School of Medicine24
+ 18 more
Also attended The Wharton School1,482
.jpeg)
+ 1,476 more
Shared employers
Also worked at Biogen27
+ 21 more
Also worked at Bain Capital113
+ 107 more
Also worked at McKinsey & Company1,457
+ 1,451 more